668P First-in-human phase I dose escalation study of ALG.APV-527, a 5T4 tumor antigen-conditional 4-1BB bispecific antibody, in patients with advanced solid tumors, demonstrates po... von Marron, T., Rosen, S., Orr, D., Powderly, J., Khaskhely, N., Bonham, L., Nelson, M., Taromino, C., Taylor, D., Kumer, J., Ellmark, P., Fritzell, S., Ambarkhane, S.V., Huebner, D., Alahmadi, A.

Volltext

280MO CD40 agonist mitazalimab combined with mFOLFIRINOX (mFFX) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Primary analysis of the OPTIMIZE-1 phase Ib/II... von Macarulla Mercade, T., Borbath, I., Geboes, K., Lambert, A., Cassier, P., Prenen, H., Mitry, E., Blanc, J.F., Pilla, L., Feliu, J., Rodriguez, M., Pazo Cid, R.A., Gallego Jimenez, I., Gomez Jimenez, D., Smith, K.E., Nordbladh, K., Ellmark, P., Pico de Coaña, Y., Ambarkhane, S.V., van Laethem, J-L.

Volltext